{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:24:47Z","timestamp":1791267887736,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.ejogrb.2011.02.005","type":"journal-article","created":{"date-parts":[[2011,4,18]],"date-time":"2011-04-18T13:03:47Z","timestamp":1303131827000},"page":"18-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Atazanavir in pregnancy: impact on neonatal hyperbilirubinemia"],"prefix":"10.1016","volume":"157","author":[{"given":"Laurent","family":"Mandelbrot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Mazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Floch-Tudal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Crenn-Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marc","family":"Treluyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Herinomenzanahary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Peytavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2011.02.005_bib0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/QAD.0b013e3282f3d63c","article-title":"Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort","volume":"22","author":"Warszawski","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.ejogrb.2011.02.005_bib0010","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1086\/427287","article-title":"Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy","volume":"40","author":"European Collaborative Study","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"13","key":"10.1016\/j.ejogrb.2011.02.005_bib0015","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/01.aids.0000242814.42344.77","article-title":"Mitochondrial dysfunction following perinatal exposure to nucleoside analogues","volume":"20","author":"Blanche","year":"2006","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.ejogrb.2011.02.005_bib0020","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/507645","article-title":"Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study","volume":"194","author":"Pacheco","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejogrb.2011.02.005_bib0025","unstructured":"Public Health Service Task Force Recommendations. Use of antiretroviral drugs in pregnant hiv-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. http:\/\/www.aidsinfo.nih.gov\/guidelines\/, last accessed Feb 15, 2010."},{"key":"10.1016\/j.ejogrb.2011.02.005_bib0030","series-title":"Prise en charge m\u00e9dicale des personnes infect\u00e9es par le VIH","year":"2010"},{"issue":"3","key":"10.1016\/j.ejogrb.2011.02.005_bib0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s15010-008-8010-6","article-title":"Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts","volume":"37","author":"Torti","year":"2009","journal-title":"Infection"},{"issue":"November (11)","key":"10.1016\/j.ejogrb.2011.02.005_bib0040","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1124\/dmd.105.005447","article-title":"In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation","volume":"33","author":"Zhang","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ejogrb.2011.02.005_bib0045","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1345\/aph.1A016","article-title":"Symptomatic hyperbilirubinemia with indinavir\/ritonavir-containing regimen","volume":"35","author":"Rayner","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"November (5)","key":"10.1016\/j.ejogrb.2011.02.005_bib0050","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1203\/01.PDR.0000141846.37253.AF","article-title":"Risk factors for severe hyperbilirubinemia in neonates","volume":"56","author":"Huang","year":"2004","journal-title":"Pediatr Res"},{"issue":"November (18)","key":"10.1016\/j.ejogrb.2011.02.005_bib0055","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1097\/QAD.0b013e32825a69d1","article-title":"Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer","volume":"21","author":"Ripamonti","year":"2007","journal-title":"AIDS"},{"issue":"July (1)","key":"10.1016\/j.ejogrb.2011.02.005_bib0060","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1542\/peds.114.1.297","article-title":"Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation","volume":"114","author":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia","year":"2004","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.ejogrb.2011.02.005_bib0065","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1053\/plac.2002.0838","article-title":"Evidence for carrier-mediated transport of unconjugated bilirubin across plasma membrane vesicles from human placental trophoblast","volume":"23","author":"Serrano","year":"2002","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.ejogrb.2011.02.005_bib0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/bj1940273","article-title":"Reduction of biliverdin and placental transfer of bilirubin and biliverdin in the pregnant guinea pig","volume":"194","author":"McDonagh","year":"1981","journal-title":"Biochem J"},{"key":"10.1016\/j.ejogrb.2011.02.005_bib0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1310\/0KX0-H9VH-99EE-5D0L","article-title":"Atazanavir plasma concentrations vary significantly between patients and correlate with increased serum bilirubin concentrations","volume":"7","author":"Smith","year":"2006","journal-title":"HIV Clin Trials"},{"issue":"1","key":"10.1016\/j.ejogrb.2011.02.005_bib0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/QAD.0b013e328011d7c1","article-title":"Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia","volume":"21","author":"Rodr\u00edguez-N\u00f3voa","year":"2007","journal-title":"AIDS"},{"issue":"15","key":"10.1016\/j.ejogrb.2011.02.005_bib0085","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2165\/00003088-200443150-00002","article-title":"Pharmacokinetics of antiretrovirals in pregnant women","volume":"43","author":"Mirochnick","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ejogrb.2011.02.005_bib0090","series-title":"17th conference on retroviruses and opportunistic infections","article-title":"Atazanavir pharmacokinetics with and without tenofovir during pregnancy","author":"Mirochnick","year":"2010"},{"key":"10.1016\/j.ejogrb.2011.02.005_bib0095","series-title":"17th conference on retroviruses and opportunistic infections","article-title":"Steady state pharmacokinetic of ritonavir-boosted atazanavir in 31 pregnant women before and after delivery","author":"Ripamonti","year":"2010"},{"key":"10.1016\/j.ejogrb.2011.02.005_bib0100","series-title":"Program and abstracts of the 5th IAS conference on HIV pathogenesis, treatment, and prevention","article-title":"The safety, efficacy, and steady state pharmacokinetics of atazanavir\/ritonavir (ATV\/r) once daily given in combination with twice daily AZT\/3TC during pregnancy: results of study AI424182","author":"Conradie","year":"2009"},{"issue":"January (2)","key":"10.1016\/j.ejogrb.2011.02.005_bib0105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.aids.0000202653.49020.dd","article-title":"Human placental transfer of atazanavir: a case report","volume":"20","author":"Lechelt","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.ejogrb.2011.02.005_bib0110","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ajog.2004.01.034","article-title":"Maternal\u2013fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus","volume":"191","author":"Chappuy","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2011.02.005_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2009\/726593","article-title":"Functional role of P-glycoprotein and binding protein effect on the placental transfer of lopinavir\/ritonavir in the ex vivo human perfusion model","author":"Ceccaldi","year":"2009","journal-title":"Obstet Gynecol Int"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211511001175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211511001175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:24:52Z","timestamp":1759555492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211511001175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0301211511001175"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2011.02.005","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atazanavir in pregnancy: impact on neonatal hyperbilirubinemia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2011.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}